Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
4(40.0%)
Phase 2
4(40.0%)
Phase 3
2(20.0%)
10Total
Phase 1(4)
Phase 2(4)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT05765487Phase 1Completed

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

Role: collaborator

NCT04948151Phase 2Unknown

Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

Role: lead

NCT01874626Phase 3Completed

Efficacy and Safety of SST 0225, a Topical Ibuprofen Cream, in the Treatment of Pain Associated With Acute Ankle Sprain

Role: lead

NCT02390960Phase 2Completed

Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED

Role: lead

NCT02570282Phase 2Completed

Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder

Role: lead

NCT02597634Phase 3Completed

Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)

Role: lead

NCT02339129Phase 2Completed

Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness

Role: lead

NCT02364882Phase 1Completed

A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women

Role: lead

NCT01986673Phase 1Completed

Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults

Role: lead

NCT01986660Phase 1Completed

Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults

Role: lead

All 10 trials loaded